Lupin gets FDA approval for Generic Actos
11 April 2014 | News | By BioSpectrum Bureau
Lupin gets FDA approval for Generic Actos
Approval granted!
Actos Tablets had annual US sales of US $236 million.
Lupin's Pioglitazone Tablets USP, 15 mg, 30 mg, and 45 mg are the AB-rated generic equivalents of Takeda's Actos Tablets 15 mg, 30 mg, and 45 mg and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings.
